RotaTeq

Background

ROTATEQ® is a live, oral pentavalent vaccine indicated for the prevention of rotavirus gastroenteritis. ROTATEQ® was approved by the United States FDA in February 2006, has been approved in seventy other countries and has launched in forty-two of these countries.

Therapeutic Area

Gastroenterology

Acquisition Date

Apr 2008

Marketer

Marketer

Seller